Suppression of Iron-Regulatory Hepcidin by Vitamin D
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The antibacterial protein hepcidin regulates the absorption, tissue distribution, and extracellular concentration of iron by suppressing ferroportin-mediated export of cellular iron. In CKD, elevated hepcidin and vitamin D deficiency are associated with anemia. Therefore, we explored a possible role for vitamin D in iron homeostasis. Treatment of cultured hepatocytes or monocytes with prohormone 25-hydroxyvitamin D or active 1,25-dihydroxyvitamin D decreased expression of hepcidin mRNA by 0.5-fold, contrasting the stimulatory effect of 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D on related antibacterial proteins such as cathelicidin. Promoter-reporter and chromatin immunoprecipitation analyses indicated that direct transcriptional suppression of hepcidin gene (HAMP) expression mediated by 1,25-dihydroxyvitamin D binding to the vitamin D receptor caused the decrease in hepcidin mRNA levels. Suppression of HAMP expression was associated with a concomitant increase in expression of the cellular target for hepcidin, ferroportin protein, and decreased expression of the intracellular iron marker ferritin. In a pilot study with healthy volunteers, supplementation with a single oral dose of vitamin D (100,000 IU vitamin D2) increased serum levels of 25D-hydroxyvitamin D from 27±2 ng/ml before supplementation to 44±3 ng/ml after supplementation (P<0.001). This response was associated with a 34% decrease in circulating levels of hepcidin within 24 hours of vitamin D supplementation (P<0.05). These data show that vitamin D is a potent regulator of the hepcidin-ferroportin axis in humans and highlight a potential new strategy for the management of anemia in patients with low vitamin D and/or CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CKD with a glomerular filtration rate (GFR) < 40 ml/min/m2 results in insufficient or deregulated production of EPO and of 1, 25-dihydroxy-cholecalciferole, both of which are negative regulators of HAMP [85, 86].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“Importantly, pilot clinical studies demonstrated that vitamin D supplementation can decrease hepcidin levels in healthy volunteers (Bacchetta et al., 2014) and early stage CKD patients (Zughaier et al., 2014).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Bacchetta et al., 2014
In the citing paper
“Biochemical studies showed that binding of 1,25-dihydroxy-vitamin D to its receptor directly suppresses hepcidin transcription by binding to a promoter element (Bacchetta et al., 2014).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Bacchetta et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924
Self-citationCutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,637
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Gombart, A. F., Borregaard, N., & Koeffler, H. P. (2005) · The FASEB Journal · doi:10.1096/fj.04-3284com · Cited by 1,136
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
Yuk, J.-M., Shin, D.-M., Lee, H.-M., Yang, C.-S., Jin, H. S., Kim, K.-K., Lee, Z.-W., Lee, S.-H., Kim, J.-M., & Jo, E.-K. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.08.004 · Cited by 787
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity
Adams, J. S., & Hewison, M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0716 · Cited by 775
Self-citationHepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686
Cited by
Lopez, A., Cacoub, P., Macdougall, I. C., & Peyrin-Biroulet, L. (2016) · The Lancet · doi:10.1016/s0140-6736(15)60865-0 · Cited by 1,492
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Impact of vitamin D on immune function: lessons learned from genome-wide analysis
Chun, R. F., Liu, P. T., Modlin, R. L., Adams, J. S., & Hewison, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00151 · Cited by 399
“The increasing availability of gene/protein expression databases for different cell types means that this type of strategy is likely to become a more prominent feature of genome-wide expression analyses in the future.”
BackgroundSelf-citationVitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
L Bishop, E., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2021) · JBMR Plus · doi:10.1002/jbm4.10405 · Cited by 392
“1).((49)) In contrast to CAMP and DEFB4, the direct microbiocidal properties of HAMP are not as apparent.”
BackgroundSelf-citationMECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V., Nair, N., Babalyan, V., Hutchings, N., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0665 · Cited by 343
Self-citation
Metadata
- Authors
- Bacchetta, J., Zaritsky, J. J., Sea, J. L., Chun, R. F., Lisse, T. S., Zavala, K., Nayak, A., Wesseling-Perry, K., Westerman, M., Hollis, B. W., Salusky, I. B., & Hewison, M.
- Affiliations
- École Normale Supérieure de Lyon (FR)
- University of California, Los Angeles (US)
- Intrinsic LifeSciences (United States) (US)
- Medical University of South Carolina (US)
- Corresponding author
- Bacchetta, Justine
- Sea, Jessica L.
- Chun, Rene F.
- Lisse, Thomas S.
- Zavala, Kathryn
- Hewison, Martin
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2014-03
- Volume
- 25
- Issue
- 3
- Pages
- 564-572
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3935584
- OpenAlex
- W2151191790
- Cited by
- 350
- References
- 48
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 25 · 2023: 32 · 2022: 31 · 2021: 40 · 2020: 24 · 2019: 28 · 2018: 36 · 2017: 27 · 2016: 26 · 2015: 22 · 2014: 13
- FWCI
- 14.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Académie française
- National Institutes of Health (1ul1rr033176-01, UL1TR000124, KL2TR000122)
- University of California, Los Angeles
- National Institute of General Medical Sciences (T32GM007185)
- National Institute of Allergy and Infectious Diseases (P30AI028697)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK091672, DK-67563, DK-35423, DK0911672, R01DK035423, R01DK067563)
- National Center for Research Resources (UL1-RR-033176)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hepcidin, vitamin D, 1,25-dihydroxyvitamin D, vitamin D receptor, ferroportin, iron homeostasis, anemia of chronic kidney disease, vitamin D supplementation, cathelicidin, ferritin
- MeSH terms
- Ferroportin, Adult, Animals, Female, Ferritins, Humans, Male, Middle Aged, Pilot Projects, Vitamin D, 3T3 Cells, Antimicrobial Cationic Peptides, Cation Transport Proteins, Mice, Cathelicidins, Hep G2 Cells, Healthy Volunteers, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of Iron-Regulatory Hepcidin by Vitamin D. https://app.cochat.ai/papers/10.1681/asn.2013040355
- The paper
- Bacchetta, J., Zaritsky, J. J., Sea, J. L., Chun, R. F., Lisse, T. S., Zavala, K., Nayak, A., Wesseling-Perry, K., Westerman, M., Hollis, B. W., Salusky, I. B., & Hewison, M. (2014). Suppression of Iron-Regulatory Hepcidin by Vitamin D. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2013040355
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.